These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 30524898)

  • 1. Sphingosine kinase 1 overexpression contributes to sunitinib resistance in clear cell renal cell carcinoma.
    Xu Y; Dong B; Wang J; Zhang J; Xue W; Huang Y
    Oncoimmunology; 2018; 7(12):e1502130. PubMed ID: 30524898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sphingosine kinase 1 regulates lipid metabolism to promote progression of kidney renal clear cell carcinoma.
    Zhao L; Wang Z; Xu Y; Zhang P; Qiu J; Nie D; Wu G; Chen C; Chang Y; Xia Q
    Pathol Res Pract; 2023 Aug; 248():154641. PubMed ID: 37467634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soyasapogenol B exhibits anti-growth and anti-metastatic activities in clear cell renal cell carcinoma.
    Wang L; Wang J; Zhao H; Jiang G; Feng X; Sui W; Liu H
    Naunyn Schmiedebergs Arch Pharmacol; 2019 May; 392(5):551-563. PubMed ID: 30607469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Essential role for SphK1/S1P signaling to regulate hypoxia-inducible factor 2α expression and activity in cancer.
    Bouquerel P; Gstalder C; Müller D; Laurent J; Brizuela L; Sabbadini RA; Malavaud B; Pyronnet S; Martineau Y; Ader I; Cuvillier O
    Oncogenesis; 2016 Mar; 5(3):e209. PubMed ID: 26974204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p21-activated kinase 1 determines stem-like phenotype and sunitinib resistance via NF-κB/IL-6 activation in renal cell carcinoma.
    Zhu Y; Liu H; Xu L; An H; Liu W; Liu Y; Lin Z; Xu J
    Cell Death Dis; 2015 Feb; 6(2):e1637. PubMed ID: 25675297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hispidulin suppresses tumor growth and metastasis in renal cell carcinoma by modulating ceramide-sphingosine 1-phosphate rheostat.
    Gao MQ; Gao H; Han M; Liu KL; Peng JJ; Han YT
    Am J Cancer Res; 2017; 7(7):1501-1514. PubMed ID: 28744400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sphingosine kinase 1 overexpression contributes to cetuximab resistance in human colorectal cancer models.
    Rosa R; Marciano R; Malapelle U; Formisano L; Nappi L; D'Amato C; D'Amato V; Damiano V; Marfè G; Del Vecchio S; Zannetti A; Greco A; De Stefano A; Carlomagno C; Veneziani BM; Troncone G; De Placido S; Bianco R
    Clin Cancer Res; 2013 Jan; 19(1):138-47. PubMed ID: 23166225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of cellular S1P levels with a novel, potent and specific inhibitor of sphingosine kinase-1.
    Schnute ME; McReynolds MD; Kasten T; Yates M; Jerome G; Rains JW; Hall T; Chrencik J; Kraus M; Cronin CN; Saabye M; Highkin MK; Broadus R; Ogawa S; Cukyne K; Zawadzke LE; Peterkin V; Iyanar K; Scholten JA; Wendling J; Fujiwara H; Nemirovskiy O; Wittwer AJ; Nagiec MM
    Biochem J; 2012 May; 444(1):79-88. PubMed ID: 22397330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of SPHK1 associated with targeted therapy resistance in predicting poor prognosis in renal cell carcinoma.
    Bao JM; Zhi X; Yuan HY; Chen TY; Chen MK; Zhou JH; Xue KY; Yang JK; Liu CD
    Transl Cancer Res; 2023 Mar; 12(3):572-584. PubMed ID: 37033345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FTY720 (Fingolimod) Inhibits HIF1 and HIF2 Signaling, Promotes Vascular Remodeling, and Chemosensitizes in Renal Cell Carcinoma Animal Model.
    Gstalder C; Ader I; Cuvillier O
    Mol Cancer Ther; 2016 Oct; 15(10):2465-2474. PubMed ID: 27507852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sphingosine kinase 1 is a potential therapeutic target for nasopharyngeal carcinoma.
    Li W; Li J; Wang Y; Zhang K; Li N; Tian Z; Ni B; Wang H; Ruan Z
    Oncotarget; 2016 Dec; 7(49):80586-80598. PubMed ID: 27811359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SPHK1 promotes metastasis of thyroid carcinoma through activation of the S1P/S1PR3/Notch signaling pathway.
    Zhao Z; Ma J; Hu B; Zhang Y; Wang S
    Exp Ther Med; 2018 Jun; 15(6):5007-5016. PubMed ID: 29805524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of miR-15b Promotes Resistance to Sunitinib in Renal Cell Carcinoma.
    Lu L; Li Y; Wen H; Feng C
    J Cancer; 2019; 10(15):3389-3396. PubMed ID: 31293642
    [No Abstract]   [Full Text] [Related]  

  • 14. Pramipexole and Fingolimod exert neuroprotection in a mouse model of Parkinson's disease by activation of sphingosine kinase 1 and Akt kinase.
    Motyl J; Przykaza Ł; Boguszewski PM; Kosson P; Strosznajder JB
    Neuropharmacology; 2018 Jun; 135():139-150. PubMed ID: 29481916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
    Rabjerg M
    Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sphingosine kinase 1 promotes tumour cell migration and invasion via the S1P/EDG1 axis in hepatocellular carcinoma.
    Bao M; Chen Z; Xu Y; Zhao Y; Zha R; Huang S; Liu L; Chen T; Li J; Tu H; He X
    Liver Int; 2012 Feb; 32(2):331-8. PubMed ID: 22098666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AP-1 regulates sphingosine kinase 1 expression in a positive feedback manner in glomerular mesangial cells exposed to high glucose.
    Huang K; Huang J; Chen C; Hao J; Wang S; Huang J; Liu P; Huang H
    Cell Signal; 2014 Mar; 26(3):629-38. PubMed ID: 24342046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA HULC promotes non-small cell lung cancer cell proliferation and inhibits the apoptosis by up-regulating sphingosine kinase 1 (SPHK1) and its downstream PI3K/Akt pathway.
    Liu L; Zhou XY; Zhang JQ; Wang GG; He J; Chen YY; Huang C; Li L; Li SQ
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8722-8730. PubMed ID: 30575912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triple Negative Breast Cancer Depends on Sphingosine Kinase 1 (SphK1)/Sphingosine-1-Phosphate (S1P)/Sphingosine 1-Phosphate Receptor 3 (S1PR3)/Notch Signaling for Metastasis.
    Wang S; Liang Y; Chang W; Hu B; Zhang Y
    Med Sci Monit; 2018 Apr; 24():1912-1923. PubMed ID: 29605826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sphk1/S1P/S1PR1 Signaling is Involved in the Development of Autoimmune Thyroiditis in Patients and NOD.H-2
    Han C; He X; Xia X; Guo J; Liu A; Liu X; Wang X; Li C; Peng S; Zhao W; Zhou M; Shi X; Li Y; Li Y; Shan Z; Teng W
    Thyroid; 2019 May; 29(5):700-713. PubMed ID: 30963819
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.